SomnoMed Ltd SOMNF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.39
- Day Range
- $0.28–0.28
- 52-Week Range
- $0.28–0.91
- Bid/Ask
- $0.02 / $1.86
- Market Cap
- $30.41 Mil
- Volume/Avg
- 3,000 / 3,000
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.54
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 22
- Website
- https://www.somnomed.com/au
Comparables
Valuation
|
Metric
|
SOMNF
|
SWAV
|
BONEX
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 84.20 | 67.42 |
Price/Book Value | 1.93 | 18.10 | 29.18 |
Price/Sales | 0.54 | 17.12 | 29.81 |
Price/Cash Flow | — | 52.11 | 525.42 |
Price/Earnings
SOMNF
SWAV
BONEX
Financial Strength
|
Metric
|
SOMNF
|
SWAV
|
BONEX
|
|---|---|---|---|
Quick Ratio | 1.44 | 10.61 | 2.99 |
Current Ratio | 1.73 | 11.76 | 4.03 |
Interest Coverage | −1.69 | 26.24 | 1.22 |
Quick Ratio
SOMNF
SWAV
BONEX
Profitability
|
Metric
|
SOMNF
|
SWAV
|
BONEX
|
|---|---|---|---|
Return on Assets (Normalized) | −15.36% | 19.87% | 53.88% |
Return on Equity (Normalized) | −37.96% | 35.18% | 69.96% |
Return on Invested Capital (Normalized) | −15.30% | 22.54% | 67.12% |
Return on Assets
SOMNF
SWAV
BONEX
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Qsqmbcdvn | Lmtrky | $182.7 Bil | |
SYK
| Stryker Corp | Rkgljclqkh | Wqfx | $124.6 Bil | |
MDT
| Medtronic PLC | Jgvxblgwv | Snxqdd | $105.2 Bil | |
BSX
| Boston Scientific Corp | Flvwkctkw | Bpbvnz | $99.1 Bil | |
EW
| Edwards Lifesciences Corp | Vscdgbqck | Pxmhtg | $52.0 Bil | |
DXCM
| DexCom Inc | Zjhbmnqqm | Tqr | $51.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Bfznwplmzr | Ktwz | $24.5 Bil | |
ALGN
| Align Technology Inc | Wbphjsrn | Kdznss | $22.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Ckcgcvnql | Twvrw | $18.3 Bil | |
PODD
| Insulet Corp | Fnqpmxcbv | Grpzx | $11.6 Bil |